Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05911997

MTC Versus FMT in for RCDI

Comparison of MTC01 vs FMT for the Treatment of Recurrent Clostridioides Difficile Infection

Status
Recruiting
Phase
Phase 1
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Icahn School of Medicine at Mount Sinai · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Investigating four different treatment of MTC or FMT

Detailed description

The purpose of this research study is to compare two different treatments for patients with recurrent Clostridiodies difficile infections: MTC01 vs fecal microbiota transplantation (FMT). FMT is the transfer of bacteria from a healthy donor's colon to a recipient's colon. To do this, stool from a healthy donor is blended with salt water and made into a liquid solution rich in bacteria. This solution is sprayed into the recipient's colon during a colonoscopy. This treatment is now considered standard medical care for recurrent Clostridioides difficile infections. One FMT dose contains the entire collection of microbes in a healthy donor and is made up of billions of microbes. Each dose of FMT is different from the next and it is unknown exactly what microbes are present in each dose.

Conditions

Interventions

TypeNameDescription
DRUGMTC 01Slurry to be administered via colonoscopy
DRUGFecal Microbiota Transplantation (FMT)Stool from a healthy donor is blended with salt water and made into a liquid solution rich in bacteria. This solution is sprayed into the recipient's colon during a colonoscopy

Timeline

Start date
2024-01-08
Primary completion
2026-07-25
Completion
2026-07-25
First posted
2023-06-22
Last updated
2025-11-10

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT05911997. Inclusion in this directory is not an endorsement.